首页 › 基金 › Propel Bio Management, LLC › ABEO
Propel Bio Management, LLC 对 ABEO 的持仓历史
ABEONA THERAPEUTICS INC · 医疗保健
Propel Bio Management, LLC 在 Q3 2026 的 13F 申报中披露持有 ABEO(ABEONA THERAPEUTICS INC)956,007 股,市值约 US$5.0M,约占其申报组合的 2.66%,在其申报持仓中市值排名第 12 位。 Propel Bio Management, LLC 最近 10 个申报季度中有 10 个季度披露了 ABEO 持仓,最早可追溯至 Q2 2024。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
Propel Bio Management, LLC 对 ABEO 的持仓演变
Propel Bio Management, LLC 于 Q2 2024 首次披露 ABEO 持仓:1,248,044 股(约 US$5.3M)。 该持仓在 Q2 2026 达到峰值 983,070 股,市值约 US$6.1M。 在 10 次申报中,Propel Bio Management, LLC 2 次增持、4 次减持、3 次保持不变。 最近一期申报(Q3 2026)显示持股 956,007 股、市值约 US$5.0M,环比减持 -27,063 股。。 持仓曾出现大幅变动:Q3 2024 减持约 50% (随后一个季度股价下跌 12%)、Q2 2025 增持约 56% (随后一个季度股价下跌 7%)、Q1 2026 增持约 60% (随后一个季度股价上涨 38%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2024 | 1.25M | $5.29M | 新进 |
| Q3 2024 | 624.02K | $3.94M | 减持 |
| Q4 2024 | 624.02K | $3.48M | 持有 |
| Q1 2025 | 624.02K | $2.97M | 持有 |
| Q2 2025 | 974.02K | $5.53M | 增持 |
| Q3 2025 | 974.02K | $5.14M | 持有 |
| Q4 2025 | 830.78K | $4.38M | 减持 |
| Q1 2026 | 1.33M | $6.01M | 增持 |
| Q2 2026 | 983.07K | $6.08M | 减持 |
| Q3 2026 | 956.01K | $5.02M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 ABEO 与 13F 数据
ABEO(ABEONA THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 34 只申报持有 ABEO,申报仓位最大的包括:Cable Car Capital, LP (US$18.6M), AIGH Capital Management LLC (US$15.2M), AWM Investment Company, Inc. (US$9.2M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 ABEO 的基金
- Cable Car Capital, LP 3.01M 股 · $18.59M · Q2 2026
- AIGH Capital Management LLC 2.90M 股 · $15.22M · Q3 2026
- AWM Investment Company, Inc. 1.49M 股 · $9.18M · Q2 2026
- Diametric Capital, LP 755.02K 股 · $4.67M · Q2 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 693.44K 股 · $3.64M · Q3 2026
- Stonepine Capital Management, LLC 557.28K 股 · $3.44M · Q2 2026
- Knoll Capital Management, LLC 485.51K 股 · $3.00M · Q2 2026
更多关于 Propel Bio Management, LLC
常见问题
How long has Propel Bio Management, LLC held ABEO?
Propel Bio Management, LLC has disclosed ABEO holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
What is Propel Bio Management, LLC's current position in ABEO?
As of Q3 2026, Propel Bio Management, LLC holds 956.01K shares of ABEO (ABEONA THERAPEUTICS INC), valued at $5.02M, representing 2.66% of its reported portfolio and ranking #12.
Has Propel Bio Management, LLC been buying or selling ABEO?
In the latest 13F filing (Q3 2026), Propel Bio Management, LLC reduced its position in ABEO. The position peaked in Q2 2026 at 983.07K shares.
Which other funds hold ABEO?
Other major institutional holders of ABEO include Cable Car Capital, LP, AIGH Capital Management LLC, AWM Investment Company, Inc., among 34 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.